New weight loss drug TE-8105 tested in early human trials
NCT ID NCT06471530
First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 22 times
Summary
This early-stage study tested a new drug called TE-8105 in 38 overweight or obese adults without diabetes. The main goal was to check if the drug is safe and to see how it affects body weight. Participants received injections of the drug, and researchers monitored side effects and weight changes over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CMAX Clinical Research
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.